Recolony AG
Entity

  • Recolony AG

    Created in 2022
  • BETA

    Up & running (A)
    Existing signals show a regular activity

  • Social networks

    26 1,215

  • Activities

    biotech deeptech

  • Technologies

    Synthetic Biology

  • Entity types

    Startup

  • Location

    Zürich, Switzerland

    Zürich

    Switzerland

  • Employees

    Scale: 2-10

    Estimated: 8

  • Engaged corporates

    1
    0 0

  • Added in Motherbase

    1 year, 3 months ago
Description
  • Value proposition

    Bacteria-based cancer therapy

    Recolony is a Swiss biotech start-up with the goal of developing a bacteria-based oral therapy to treat and prevent cancer.

  • Recolony | Bacteria-based cancer therapy

    Recolony focuses on the development of cancer therapies that primarily consist of selected commensal bacteria of the gut microbiota. By harnessing the potential of beneficial gut microbiota, Recolony aims to develop a completely new class of drugs for the treatment and prevention of cancer.

    • https://www.recolony.ch/
Corporate interactions BETA
Corporate TypeTweets Articles
Seventure Partners
Seventure Partners
Startup accelerator & VC, Venture Capital and Private Equity Principals
Seventure Partners
Startup accelerator & VC, Venture Capital and Private Equity Principals 		Other

31 Oct 2023


Similar entities
Last news
Show all articles
Social network dynamics